These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17632240)

  • 1. Rating rater improvement: a method for estimating increased effect size and reduction of clinical trial costs.
    Cogger KO
    J Clin Psychopharmacol; 2007 Aug; 27(4):418-20. PubMed ID: 17632240
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative meta-analysis of Clinical Global Impressions change in antidepressant trials.
    Spielmans GI; McFall JP
    J Nerv Ment Dis; 2006 Nov; 194(11):845-52. PubMed ID: 17102709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From trial and error to trial simulation. Part 1: the importance of model-based drug development for antidepressant drugs.
    Santen G; van Zwet E; Danhof M; Della Pasqua O
    Clin Pharmacol Ther; 2009 Sep; 86(3):248-54. PubMed ID: 19657333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comments on "Clinical trials of antidepressants: time to shift to a new model" by Dr Katz.
    Rickels K; Robinson DS
    J Clin Psychopharmacol; 2009 Apr; 29(2):197-8; author reply 198-9. PubMed ID: 19512995
    [No Abstract]   [Full Text] [Related]  

  • 5. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract]   [Full Text] [Related]  

  • 6. Generalizability of antidepressant efficacy trials.
    Zimmerman M; Posternak MA; Chelminski I
    Essent Psychopharmacol; 2004; 6(1):45-58. PubMed ID: 15612653
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors contributing to failed trials of new agents: can technology prevent some problems?
    Greist JH; Mundt JC; Kobak K
    J Clin Psychiatry; 2002; 63 Suppl 2():8-13. PubMed ID: 15453008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Eppendorf Mood and Motivation Scale as assessment procedure in the clinical evaluation of an antidepressive agent].
    Binz U; Wendt G
    Fortschr Med; 1982 Dec; 100(45):2111-7. PubMed ID: 6757074
    [No Abstract]   [Full Text] [Related]  

  • 9. Using longitudinal data from a clinical trial in depression to assess the reliability of its outcome scales.
    Laenen A; Alonso A; Molenberghs G; Vangeneugden T; Mallinckrodt CH
    J Psychiatr Res; 2009 Apr; 43(7):730-8. PubMed ID: 18986657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are the effects of rater training sustainable? Results from a multicenter clinical trial.
    Kobak KA; Lipsitz J; Williams JB; Engelhardt N; Jeglic E; Bellew KM
    J Clin Psychopharmacol; 2007 Oct; 27(5):534-5. PubMed ID: 17873701
    [No Abstract]   [Full Text] [Related]  

  • 11. Are 2-week trials sufficient to indicate efficacy?
    Montgomery SA
    Psychopharmacol Bull; 1995; 31(1):41-4. PubMed ID: 7675988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to design a clinical trial.
    Curtis BM; Barrett BJ; Parfrey PS
    Methods Mol Med; 2003; 86():475-89. PubMed ID: 12886789
    [No Abstract]   [Full Text] [Related]  

  • 13. Are two antidepressant mechanisms better than one? Issues in clinical trial design and analysis.
    Leon AC
    J Clin Psychiatry; 2004; 65 Suppl 4():31-6. PubMed ID: 15046539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From trial and error to trial simulation. Part 2: an appraisal of current beliefs in the design and analysis of clinical trials for antidepressant drugs.
    Santen G; Horrigan J; Danhof M; Della Pasqua O
    Clin Pharmacol Ther; 2009 Sep; 86(3):255-62. PubMed ID: 19675543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel approach to rater training and certification in multinational trials.
    Jeglic E; Kobak KA; Engelhardt N; Williams JB; Lipsitz JD; Salvucci D; Bryson H; Bellew K
    Int Clin Psychopharmacol; 2007 Jul; 22(4):187-91. PubMed ID: 17519640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive statistical analysis following sample size modification based on interim review of effect size.
    Hung HM; Cui L; Wang SJ; Lawrence J
    J Biopharm Stat; 2005; 15(4):693-706. PubMed ID: 16022173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpreting antidepressant clinical trials.
    Sussman N
    Ann Clin Psychiatry; 2007; 19(4):215-20. PubMed ID: 18058279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confounding influence of extraneous symptoms on clinical global impression ratings for depression.
    Targum SD; Busner J; Dunn J
    J Clin Psychopharmacol; 2008 Oct; 28(5):587-9. PubMed ID: 18794667
    [No Abstract]   [Full Text] [Related]  

  • 19. Justifying a "fast acting" claim for antidepressant drugs.
    Overall JE
    Psychopharmacol Bull; 1995; 31(1):45-55. PubMed ID: 7675989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptics as antidepressants.
    Robertson MM; Trimble MR
    Neuropharmacology; 1981 Dec; 20(12B):1335-6. PubMed ID: 6119646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.